Cost: US $250 to $600 per session, often a series of 4 to 8
The above non-proliferative, multinucleated cells are characterized by elevated intercellular spaces, being developed on semi-permeable membranes
Clinical trials show users experience 1015% reductions in LDL cholesterol and meaningful increases in protective HDL cholesterol within 612 months of treatment
However, we observed no abnormality in the fluctuation of BT, as seen in Ghrl / mice
Broader Metabolic Benefits Reduces systemic inflammation Enhances mitochondrial health Improves insulin resistance Supports healthy aging How MOTS-c Compares to Other Peptides Ideal Candidates for MOTS-c Central obesity or visceral fat Prediabetes or insulin resistance Metabolic syndrome Aging with muscle loss or fatigue Poor mitochondrial function Clinical Use Best used in cycles (e.g., 8 weeks on, 4 weeks off) Monitor: IGF-1, glucose, CRP, lipid panel, DEXA scan Integration into a Metabolic Plan Combine MOTS-c with: Anti-inflammatory diet Intermittent fasting Resistance and aerobic training CJC-1295, Ipamorelin, or Tesamorelin for synergistic effects Is MOTS-c Safe
